Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001
We would like to thank Drs Powell and Dawber for their thoughtful letter about our editorial. Perhaps the seeds of progress can be found among some of their comments. We would like to draw special attention to their third reference,1 which is useful reading for clinicians who are struggling with the treatment of inflammatory, scarring alopecia. In this referenced article, Drs Powell, Dawber, and Gatter describe 18 patients with inflammatory, scarring alopecia whose lesions were culture positive for S aureus. These patients had received no long-term benefit from multiple trials of antistaphylococcal antibiotics, but did respond to 1 or more prolonged (10-week) courses of treatment with rifampicin plus clindamycin. Patients remained free of recurrences for at least several months after cessation of treatment.
Sperling LC, Whiting D, Solomon A. Folliculitis Decalvans and Tufted Folliculitis Are Specific Infective Diseases That May Lead to Scarring, but Are Not a Subset of Central Centrifugal Scarring Alopecia. Arch Dermatol. 2001;137(3):373–374. doi:
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: